Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32A D V A M E D 2 0 1 6 A N N U A L R E P O R T u P AY M E N T A N D H E A LT H C A R E D E L I V E R Y PROTECTING ACCESS TO INNOVATION The advanced medical technology industry creates life-saving and life-enhancing innovations every day, and Medicare patients are a major beneficiary of these advances. AdvaMed’s Payment and Health Care Delivery department works closely with the Centers for Medicare and Medicaid Services (CMS) to ensure patient access to innovations through appropriate coverage, coding and payment policies – the importance of which is magnified when such policies are replicated by private payers. ADVAMED’S VALUE INITIATIVE In 2016, AdvaMed undertook an initiative to develop a compre- hensive approach for assessing the value of medical technologies in new payment models, aimed at helping members demonstrate the value of products in a consistent and effective fashion, to support positive coverage and payment decisions. The initiative provides a counter perspective to other frameworks that focus on the cost impacts of technologies, and takes into account a broad range of technologies, stakeholder perspectives and value drivers, including clinical, non-clinical, care delivery economics, and public/population health impacts. In conjunction with ongoing work identifying gaps in medtech quality measurement, the initiative will better position AdvaMed members to compete in a rapidly changing care delivery environment. 21ST CENTURY CURES In December, Congress passed and President Obama signed the 21st Century Cures Act, designed to accelerate the discovery, development and delivery of 21st century cures for patients in need. AdvaMed played a prominent role – working in concert with many allied stakeholder groups – in proposing and advancing key health care delivery system reforms, including language in the final bill that requires greater transparency in local coverage decisions, and a retroactive delay in the applica- tion of competitive bidding rates to non-competitively bid areas for durable medical equipment through the end of 2016. Joseph Chin, deputy director of CMS’s Coverage and Analysis Group, meets with AdvaMed Accel Board members including Martha Shadan of Rotation Medical (at right) in October to discuss steps the Medicare agency has taken to support medtech innovation. Sean Cavanaugh, CMS deputy administrator and director of the Center for Medicare, addresses attendees of AdvaMed’s annual Payment Policy Conference in April in Arlington, Va. Payment and Health Care Delivery Board Committee Chairman Timothy Ring of C.R. Bard gives Utah Senator Orrin Hatch a tour of the firm’s facility in Salt Lake City in August, ahead of discussions on key AdvaMed advocacy priorities. 10